Clinical Trial Update: A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children [Phase 3]

View source ↗

Summary

A Phase 3 comparative effectiveness trial evaluated OROS methylphenidate HCl, Ritalin (methylphenidate HCl), and placebo for treating ADHD in children; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)
• Ritalin (methylphenidate)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED